Sydney, May 18, 2026, 08:01 AEST
- ALS ended Friday at A$22.20, slipping 0.31%. The company is set to report FY26 results and a final dividend update on Monday.
- The stock fell around 0.6% last week, less than the S&P/ASX 200, which dropped about 1.3%.
- Investors wait to see if the company’s May cyber incident will impact costs, data, or revenue.
ALS Ltd trades mostly flat on the week ahead of Monday’s results. Investors are set to watch for more information on the cyber incident, updates on margins, and the size of the final dividend.
ALS plans to release its FY26 results and announce its final dividend on May 18, with a briefing set for 10 a.m. AEST. When the dateline hit, ASX cash-market trading was in pre-open. Regular trading starts at about 09:59:45 Sydney time and lasts until 16:00.
Monday doesn’t appear as a holiday on the ASX calendar. The 2026 schedule has the next planned market shutdown for King’s Birthday on June 8.
ALS shares ended Friday at A$22.20, slipping 0.31% on the day. The stock traded between A$22.05 and A$22.82. That’s roughly 0.6% below ALS’s A$22.33 close on May 8. The S&P/ASX 200 closed at 8,630.80, dropping 0.11% Friday and finishing about 1.3% down for the week.
ALS faces a test to see if first-half momentum kept up through March. In November, it posted H1 FY26 underlying revenue at A$1.66 billion, up 13.3%. Underlying EBIT came in at A$287.2 million, rising 14.7%. Underlying NPAT, which leaves out unusual or one-off items, climbed 17.2% to A$178.4 million.
ALS Chairman Nigel Garrard called margins “resilient” at the half-year. CEO Malcolm Deane said Commodities drove the first half, but Life Sciences saw “lower growth conditions”. That split could be in focus again Monday. ASX Announcements
Cyber is the newest overhang. ALS said May 5 it found unauthorised third-party access to some IT systems, which led to a temporary hit to some operations. The company said most of its operations are back, but targeted fixes are still underway and the potential impact on data is still being investigated.
ALS has told the Australian Cyber Security Centre about the cyber incident, Reuters said, and is also working with its clients, regulators and authorities. ALS has not said when the disruption started or given a timeline for full recovery.
ALS competes in a bigger testing and inspection field. SGS, Bureau Veritas, and Intertek are in the mix, and scale counts, as do lab networks. Reuters said last year Bureau Veritas and SGS talked about a merger that would create a testing and certification group with a value topping $30 billion, showing how much size matters in this business.
Analysts tracked by Investing.com put ALS’s 12-month price target at an average A$23.92, based on 14 estimates between A$16.70 and A$28. Nine analysts call the stock a buy, three say hold, and two recommend selling, so the rating is positive but mixed.
But the risks are clear. A cyber bill above forecasts, any sign of data loss, softer Life Sciences numbers, fewer mineral samples or a smaller final payout could rattle sentiment fast. The usual reporting-day risk is here too—adjusted profit might hold up, but cash flow, statutory profit or outlook could fall short.
Monday’s briefing is likely to drive sentiment this week. The schedule for shareholders after results is the final dividend record date on June 15, followed by the dividend reinvestment plan election deadline on June 16. Payment is set for July 3. The annual meeting is on July 28.
